Skip to Content

NVR TKI (Tasigna 200 mg)

Generic Name: nilotinib

Pill imprint NVR TKI has been identified as Tasigna 200 mg.

Tasigna is used in the treatment of chronic myelogenous leukemia and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Tasigna 200 mg is not a controlled substance under the Controlled Substance Act (CSA).

Tasigna 200 mg NVR TKI
Discount Card Promo
Tasigna
Generic Name:
nilotinib
Imprint:
NVR TKI
Strength:
200 mg
Color:
Yellow
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
BCR-ABL tyrosine kinase inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Manufacturer:
Novartis Pharmaceuticals
National Drug Code (NDC):
00078-0526
Inactive Ingredients:
silicon dioxide
crospovidone
gelatin
lactose monohydrate
magnesium stearate
ferric oxide red
titanium dioxide
ferric oxide yellow

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide